Outcome of gastro-oesophageal reflux-related respiratory manifestations after laparoscopic fundoplication  by Adaba, Franklin et al.
lable at ScienceDirect
International Journal of Surgery 12 (2014) 241e244
ORIGINAL RESEARCHContents lists avaiInternational Journal of Surgery
journal homepage: www.journal-surgery.netOriginal researchOutcome of gastro-oesophageal reﬂux-related respiratory
manifestations after laparoscopic fundoplication
Franklin Adaba*, Chin W. Ang 1, Anthony Perry, Martin S. Wadley, Charles S. Robertson
Department of Upper Gastrointestinal Surgery, Worcestershire Acute Hospitals NHS Trust, Charles Hastings Way, Worcester WR5 1DD, UKa r t i c l e i n f o
Article history:
Received 3 March 2013
Received in revised form
1 October 2013
Accepted 15 January 2014
Available online 24 January 2014
Keywords:
Gastro-oesophageal reﬂux
Respiratory manifestations
Laparoscopic fundoplication* Corresponding author. Tel.: þ44 07540251770.
E-mail address: uchiecoche@yahoo.co.uk (F. Adaba
1 Shared ﬁrst authorship.
1743-9191/$ e see front matter  2014 Surgical Asso
http://dx.doi.org/10.1016/j.ijsu.2014.01.005a b s t r a c t
Aims: Patients with refractory respiratory symptoms related to gastro-oesophageal reﬂux disease
(GORD) such as asthma and cough are being referred for laparoscopic fundoplication (LFP), as recom-
mended by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). However there
are limited data regarding symptomatic response to fundoplication in this group of patients.
Method: A 7 year retrospective review was performed to study the efﬁcacy of LFP in the treatment of
patients with respiratory manifestations of GORD. Patients were followed up from 4 to 6 weeks (short-
term) to 6e12 months (long-term) post-operatively.
Results: Of 208 patients who underwent LFP, 73 (35%) patients were eligible for inclusion into the study.
55 (75%) patients had improved respiratory symptoms at short-term follow-up. At long-term follow-up,
7 of these patients had recurrence of respiratory symptoms, while 4 patients had improvement not
initially apparent. No signiﬁcant predictive factor for the success or failure of surgery was identiﬁed. 190
(91%) of 208 patients had symptomatic improvement in GORD at short-term follow-up.
Conclusion: LFP is effective with the response rates over 75% in the control of respiratory manifestation
of GORD, compared to over 91% response rate in the control GOR symptoms alone. More research is
needed to identify factors to aid patient selection to improve response rate.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Gastro-oesophageal reﬂux disease (GORD) is a known cause of
respiratory and intractable extra-oesophageal symptoms such as
cough, hoarseness and asthma [4,19,21,24]. It can also exacerbate
cough in patients with pre-existing respiratory conditions. Several
articles have documented that patients with chronic cough due to
reﬂux disease have improvement of their symptoms after anti-
reﬂux surgery [1e3,6,9,14,16,19,21e24].
The relationship between cough and other symptoms of gastro-
oesophageal reﬂux disease (GORD) and factors which may predict
the response of reﬂux related cough to anti-reﬂux surgery remain
unclear [19,23]. Three mechanisms have been postulated linking
GORD with cough and these are the intra-oesophageal reﬂux,
extra-oesophageal reﬂux and micro-aspiration [4,10]. Each of these
mechanisms act by directly stimulating the cough receptors or
indirectly causing increased sensitizing to the cough reﬂex.).
ciates Ltd. Published by Elsevier LtPatients with chronic cough due to reﬂux disease or exacerba-
tion of cough in patients with pre-existing respiratory condition are
increasingly referred to Upper Gastrointestinal surgeons in the UK
for consideration of laparoscopic fundoplication (LFP) as recom-
mended by the Society of American Gastrointestinal and Endo-
scopic Surgeons (SAGES). However there are limited data to
support this practice.
The aim of this study was to evaluate the magnitude of the
short-term and long-term effect of LFP on improving gastro-oeso-
phageal reﬂux related respiratory manifestations particularly
cough and to identify any predictive factors.2. Methodology
A retrospective analysis of patients who underwent LFP from
January 2005 to January 2012 at a single center was performed.
Patients were identiﬁed through coding system from Information
Technology (IT) department and manual search of consultant’s
theatre diary. Datawas collected from patient’s notes and electronic
clinic letters. Patients who had LFP for oesophageal motility dis-
order or gastric volvulus were excluded from the study. All patients
included in the study were reviewed for symptom presentation
which included heartburn, retrosternal/epigastric pain, dysphagia,d. All rights reserved.
Table 2
Number of patients with pre-existing respiratory conditions.
Respiratory condition Number (%) of patients
Asthma 31 (14)
COPD/bronchiectasis 12 (5)
Interstitial lung disease 4 (1)
208 patients (106 
females, mean age 
53.3) 
73 with respiratory 
manifestations 
25 with cough and 
other respiratory 
symptoms 
30 with cough only 18 with other 
respiratory 
symptoms but no 
cough
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ORIGINAL RESEARCHregurgitation and cough. Patients with pre-existing respiratory
disease such as asthma, bronchiectasis and interstitial lung disease
were also collected.
Patients underwent investigations to evaluate the severity of the
reﬂux disease pre-operatively, which included pH studies, oeso-
phageal manometry, oesophagogastroduodenoscopy (OGD) and
barium meal.
Patients with intractable cough or respiratory symptoms as
primary symptom of reﬂux disease had pre-operative respiratory
assessment by the respiratory physicians prior to referral to the
Upper Gastrointestinal Surgeons. This included spirometry, lung
function test (LFT) and high resolution CT scan of thorax (HRCT).
All patients had either Laparoscopic Toupets or Nissens fundo-
plication performed by 3 experienced upper gastrointestinal sur-
geons. Patients were followed up at 4e6 weeks (short term) and
then 6e12 months (long term) following surgery to check for the
improvement of their cough and reﬂux symptoms. A reduction in
the frequency of cough or resolution of cough was considered as
improvement of cough symptoms in this study. Complications from
surgery and any post-operative investigations (pH studies, oeso-
phageal manometry, barium meal, OGD) were also noted.
3. Statistical analysis
Comparisons between two groups were made using non-
parametric continuity corrected chi-square test or a chi squared
test was used when more than two groups were analyzed. Fisher
exact test was performed for comparison when the numbers were
less than 10. Multivariate Cox regression analysis was conducted
using a stepwise forward selection approach starting with the most
signiﬁcant variable on univariate analysis including every variable
with a P-value of <0.10 sequentially. All analysis was performed
using Statview version 5.01 (SAS Institute Inc.). A P-value of <0.05
was considered signiﬁcant.
4. Results
There were 208 patients identiﬁed for the study (51% females)
withmedian of 53 years (range 17e81 years). Of these 208 patients,
73 (35%) patients underwent LFP for cough and or respiratory
symptom due to GORD. Heartburn (84%) was the most common
symptom presentation (Table 1) while asthma (14%) was the most
prevalent pre-existing respiratory condition (Table 2).
All patients had pre-operative reﬂux evaluation however, not all
results were retrievable. 167 (80%) of patients had documented
total reﬂux time (range 0.6e76.3) while 159 (76%) of patients had
documented DeMeester score (range 2.6e317.1) and 189 (90%) of
patients had documented oesophageal manometry (96% with hy-
potonic lower oesophageal sphincter). There were 176 (84%) and 56
(26%) patients who underwent pre-operative OGD and barium
swallow respectively. The median length of hospital stay post-
operatively was 2 days (range 1e13 days) including the day of
surgery.
There were 55 (75%) patients who had improved respiratory
symptoms at 4e6 weeks following surgery (Fig. 1) while no shortTable 1
Presenting symptoms of patients who had undergone LFP.
Symptom Number (%) of patients
Heartburn 176 (84)
Retrosternal/epigastric pain 102 (49)
Reﬂux/regurgitation 158 (75)
Dysphagia 51 (24)
Cough 55 (26)term data was available for 4 patients. In comparison, 190 (91.2%) of
207 patients had GOR symptoms improvement at 4e6 weeks
following surgery. The 18 (25%) patients with no improvement of
respiratory symptoms at 4e6 weeks following surgery had post-
operative investigations to exclude technical failure of fundoplica-
tion as a cause of persistent respiratory symptoms (Table 3); all of
these patients had post-operative pH studies and oesophageal
manometry which showed no evidence of signiﬁcant gastro-
oesophageal reﬂux disease. Ten (55%) patients had OGD, 3 (17%)
patients had bariummeal while 5 (28%) patients had both OGD and
barium meal post-operatively. All of these investigations ascer-
tained intact fundoplication.
At 6e12 months, 44 (62%) had improved respiratory symptoms
of which 7 patients had recurrence of respiratory symptoms, while
4 patients had improved respiratory symptoms which were not
apparent in the short-term. There were 17 patients whose long
term data were not available. The 7 patients with recurrence of
respiratory symptoms had pH studies and oesophageal manometry
which showed no evidence of signiﬁcant gastro-oesophageal reﬂux
disease. Two patients had OGD while 2 other patients had both
OGD and barium meal, all of which were normal. We therefore
found no evidence of fundoplication failure to explain their recur-
rence of respiratory symptoms.
No signiﬁcant predictive factor (gender, age, DeMeester score,
total reﬂux time) for improving respiratory symptoms was identi-
ﬁed (P > 0.05) upon regression analysis.
Dysphagia (35%) was a common side effect of LFP. There was no
mortality.
5. Discussion
The SAGES 2010 guidelines on the management of GORD sug-
gest that patients with intractable cough or worsening of respira-
tory conditions thought to be attributed to reﬂux disease are to be Over all 24 (80%) 
had improved 
symptoms at 4-
6weeks 
Overall 19 (76%) 
had improved 
symptoms at 4-
6weeks 
Overall 19 (63%) 
had improved 
symptoms at 6-12 
months 
Overall 15 (60%) 
had improved 
symptoms at 6-12 
months
Overall 12 (66%) 
had improved 
symptoms at 4-6 
weeks
Overall 10 (55%) 
had improved 
symptoms at 6-12 
months 
Fig. 1. Summary of outcome of patients with respiratory manifestation following LFP.
Table 3
18 patients who had no improved respiratory symptoms at 4e6 weeks following
surgery were subjected to investigations to ascertain the intact of fundoplication.
Post-operative test Number (%) of patients (total ¼ 18)
pH studies 18 (100)
Oesophageal manometry 18 (100)
Barium meal 8 (45)
OGD 15 (83)
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LFP. These groups of patients are increasingly being referred to our
center for consideration of LFP after having a respiratory assess-
ment by the respiratory physicians. All patients that were referred
to our center had objective conﬁrmation of reﬂux with pH studies
and oesophageal manometry prior to having LFP. Chronic cough
was the most common respiratory symptom and reason for referral
for consideration of LFP. It should be noted that all patients in the
study had a trial of anti-reﬂux medication with proton pump in-
hibitors (PPI) prior to being referred for LFP. Studies have docu-
mented some beneﬁts in improving respiratory manifestations due
to reﬂux with medical anti-reﬂux therapy [3,2,10] however anti-
reﬂux surgery is documented to provide better beneﬁts in
improving respiratory manifestations due to reﬂux compared to
anti-reﬂux medication [3,11,12,18,19,21,23,25].
From our study, we identiﬁed three groups of patients; patients
with cough only, patients with cough plus other respiratory
symptoms and patients with other respiratory symptoms only
[Fig. 1]. We considered other respiratory symptoms to be asthma,
COPD, bronchitis, interstitial lung disease and hoarseness of voice.
We observed that patients with cough only had a better improve-
ment of their cough symptoms compared to patients with cough
plus respiratory symptoms and respiratory symptoms only in the
short and long term (Fig. 1) though the number of patients were
small for a meaningful statistical analysis. This trend has also been
observed in other studies [13,19,21,23] and the reason for this trend
is unknown. Overall response rates were over 70% in the control of
respiratory manifestations. This is in keeping with short term
improvement ranges in other studies [1,7,8,15,19,21,25].
Patients who did not have improvement of respiratory mani-
festations or who had recurrence of cough symptoms were sub-
jected to pH studies, oesophageal manometry barium meal or OGD
to exclude failure of fundoplication. We found no abnormality from
these post-operative investigations to account for the persistence
or recurrence of patients’ respiratory symptoms following surgery.
It is likely that factors other than GORD may be contributing to
these patients’ cough or recurrence of cough [6,8,10,17,18,19,23,24].
It may be possible that the reﬂux is due to cough [10]. The cough-
reﬂux mechanism is thought to occur due to rapid rise in pressure
in both the thorax and the abdomen during coughingwhichmay be
sufﬁcient to overcome the lower oesophageal sphincter thereby
causing reﬂux [10]. Careful selection of patients is paramount to
improve the outcome of surgery for resolving respiratory symp-
toms. However we did not identify any signiﬁcant predictive factors
in this context.
As a quality control measure, 190 (91.2%) of 208 patients had
GOR symptoms improvement at short-term follow-up. Our study
showed that LFP has better results with typical GOR symptoms
compared to atypical symptoms which is similar to other studies
[1,4,11,19e23].
6. Conclusion
LFP is a safe procedure with low complication rates and a short
hospital stay. We have shown that it is effective with the responserates of over 70% in the control of respiratory manifestation of
GORD, compared to over 90% response rates in the control GOR
symptoms alone. It is likely that there are other causative factors to
the respiratory symptoms along with GORD. Therefore more
research is needed to identify factors to aid patient selection for LFP
to improve response rate.Ethical approval
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